Physician profile
Poone Shoureshi
NPI 1023472149
$19,516.30
in general payments reported to CMS, 2019-2025
21 companies · $1,761 in 2025
The $1,761 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $13K · 2023: $2,642 · 2024: $1,926 · 2025: $1,761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,329 · Travel and Lodging: $989 · Education: $9.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,329.42 |
| Travel and Lodging | $988.82 |
| Education | $9.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14,223.47 | 2021-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $2,690.99 | 2022-2025 | Solyx Sis System, Advantage System, Lynx System |
| Abbvie INC. | $906.72 | 2022-2025 | Botox |
| Sumitomo Pharma America, INC. | $391.11 | 2023-2025 | Gemtesa |
| Bluewind Medical | $205.03 | 2024-2025 | |
| Caldera Medical, INC | $202.03 | 2025 | |
| Urogen Pharma, INC. | $150.20 | 2022 | |
| Axonics, INC. | $148.61 | 2023-2024 | Axonics |
| Histosonics, INC. | $147.95 | 2024 | |
| Antares Pharma, INC. | $132.15 | 2024 | Xyosted |
| Pfizer INC. | $73.87 | 2024 | |
| Femselect INC. | $73.02 | 2025 | Enplace |
| Endo USA, INC. | $25.02 | 2024 | Aveed, Xiaflex |
| Telix Pharmaceuticals | $23.25 | 2024 | Illuccix |
| Teleflex LLC | $21.63 | 2024 | Urolift |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.57 | 2024 | Keytruda |
| Coloplast Corp | $19.44 | 2024 | |
| Coopersurgical, INC. | $18.14 | 2025 | Ally II Ups |
| Immunitybio, INC. | $18.14 | 2025 | |
| Calyxo, INC. | $16.67 | 2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $9.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Poone Shoureshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.